Ludovica Borsoi

Government, Health and Not for Profit

Biography

Latest publications

TARRICONE R., AMATUCCI F., ARMENI P., Banks H., BORSOI L., CALLEA G., CIANI O., COSTA F., FEDERICI C. B., TORBICA A., Marletta M. Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies Health Policy, 27 March, 2021
ROGNONI C., Cuccurullo D., BORSOI L., Bonavina L., Asti E., Crovella F., Bassi U., Carbone G., Guerini F., De Paolis P., Pessione S., Greco V. M., Baccarini E., Soliani G., Sagnelli C., Crovella C., Trapani V., De Nisco C., Eugeni E., Zanzi F., De Nicola E., Marioni A., Rosignoli A., Silvestro R., TARRICONE R., Piccoli M. Clinical outcomes and quality of life associated with the use of a biosynthetic mesh for complex ventral hernia repair: analysis of the “Italian Hernia Club” registry Scientific Reports, 2020, vol.10, no. 1
ARMENI P., BORSOI L., FORNARO G., JOMMI C., COLOMBO N., COSTA F. Cost-Effectiveness and Net Monetary Benefit of olaparib Maintenance Therapy Versus No Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-Mutated Ovarian Cancer in the Italian National Health Service Clinical Therapeutics, 2020, vol.42, no. 7, pp.1192-1209
ARMENI P., BORSOI L., FORNARO G., JOMMI C., Grossi F., COSTA F. Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non–small Cell Lung Cancer in the Italian National Health Service Clinical Therapeutics, 2020, vol.42, no. 5, pp.830-847
MEREGAGLIA M., BORSOI L., Cairns J., TARRICONE R. Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia The European Journal Of Health Economics, 2019, vol.20, no. 2, pp.181-193
FEDERICI C. B., Perego F., BORSOI L., Crosta V., Zanichelli A., Gidaro A., TARRICONE R., Cicardi M. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients BMJ Open, 2018, vol.8, no. 7, pp.e022291